Key result
This review describes recent developments in pharmacological thromboprophylaxis and acute treatment of arterial and venous thromboembolism in pregnancy to reduce maternal mortality and morbidity.
This review describes recent developments in pharmacological thromboprophylaxis and acute treatment of arterial and venous thromboembolism in pregnancy.
Answers are grounded in this paper and cite their sources.
May guide VTE decisions in pregnancy; leaves open need for RCTs to confirm safety and efficacy.
Pregnancy-associated arterial and venous thromboembolism continue to be significant causes of maternal mortality and morbidity. Many of these deaths are potentially avoidable by better identification of risk, optimal prophylaxis and management of thromboembolic complications. This review aims to describe the recent developments in pharmacological thromboprophylaxis and acute treatment of arterial and venous thromboembolism in pregnancy.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2007) conducted a review in Pregnancy-associated arterial and venous thromboembolism. Pharmacological thromboprophylaxis and acute treatment was evaluated. This review describes recent developments in pharmacological thromboprophylaxis and acute treatment of arterial and venous thromboembolism in pregnancy to reduce maternal mortality and morbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: